IS THE USE OF CALCIUM-D 3 NIKOMED JUSTIFIED FOR CORRECTION OF DISTURBED PHOSPHORUS-CALCIUM METABOLISM IN PATIENTS WITH THE PREDIALYSIS STAGE OF CHRONIC RENAL FAILURE?
https://doi.org/10.24884/1561-6274-2003-7-2-101-102
Abstract
Is the use of calcium-D 3 Nikomed justified for correction of disturbed phosphorus-calcium metabolism in patients with the predialysis stage of chronic renal failure?
About the Authors
P. V. GavrilenkovRussian Federation
I. G. Kayukov
Russian Federation
References
1. Мари Р, Греннер Д, Мейс П, Родуэл В. Биохимия человека. Мир, М.,1993; 2: 415
2. Schomig М, Ritz Е. Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites. Nephrol Dial Transplant 2000; 15 [Suppl 5]: SI8-S24
3. Cannata-Andia J.B. Pathogenesis, prevention and management of low-bone turnover. Nephrol Dial Transplant 2000;15 [Suppl 5]: S15-S17
4. Norris K.C. Secondary hyperparathyroidism: defining a model of optimal management. Dial & Transpl 1999; 28 (11): 630-640
Review
For citations:
Gavrilenkov P.V., Kayukov I.G. IS THE USE OF CALCIUM-D 3 NIKOMED JUSTIFIED FOR CORRECTION OF DISTURBED PHOSPHORUS-CALCIUM METABOLISM IN PATIENTS WITH THE PREDIALYSIS STAGE OF CHRONIC RENAL FAILURE? Nephrology (Saint-Petersburg). 2003;7(2):101-102. (In Russ.) https://doi.org/10.24884/1561-6274-2003-7-2-101-102